サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は免疫療法市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは免疫療法の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の免疫療法市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは免疫療法のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に免疫療法市場を分類しています。本研究に含まれる主な企業は：Abbvie、Amgen, Inc.、Biogen、Bristol-Myers Squibb、Celgene、Johnson & Johnson、Merck、Novartis、Pfizer、Roche

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Monoclonal Antibodies
    Therapeutic Vaccines
    Checkpoint Inhibitors
    Non-Specific Immunotherapy

用途別の市場セグメント：
    Oncology
    Inflammation
    Central Nervous System
    Others

本レポートの詳細内容
世界の免疫療法市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、免疫療法タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の免疫療法収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の免疫療法市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、免疫療法市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

免疫療法のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：免疫療法のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：免疫療法の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章免疫療法企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：免疫療法の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：免疫療法の主要企業の概要を提供し、製品の説明と仕様、免疫療法の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Immunotherapy Market
The global Immunotherapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Immunotherapy is widely used in various fields, such as Oncology, Inflammation, Central Nervous System and Others, etc. Oncology provides greatest supports to the Immunotherapy industry development. In 2023, global % revenue of Immunotherapy went into Oncology filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Immunotherapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Immunotherapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunotherapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunotherapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immunotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunotherapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc.
Market Segmentation
By Company
    Abbvie
    Amgen, Inc.
    Biogen
    Bristol-Myers Squibb
    Celgene
    Johnson & Johnson
    Merck
    Novartis
    Pfizer
    Roche

Segment by Type
    Monoclonal Antibodies
    Therapeutic Vaccines
    Checkpoint Inhibitors
    Non-Specific Immunotherapy

Segment by Application
    Oncology
    Inflammation
    Central Nervous System
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunotherapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Immunotherapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Therapeutic Vaccines
    Table 4. Key Players of Checkpoint Inhibitors
    Table 5. Key Players of Non-Specific Immunotherapy
    Table 6. Global Immunotherapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Immunotherapy Market Share by Region (2019-2024)
    Table 10. Global Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Immunotherapy Market Share by Region (2025-2030)
    Table 12. Immunotherapy Market Trends
    Table 13. Immunotherapy Market Drivers
    Table 14. Immunotherapy Market Challenges
    Table 15. Immunotherapy Market Restraints
    Table 16. Global Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Immunotherapy Revenue Share by Players (2019-2024)
    Table 18. Global Top Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2023)
    Table 19. Global Immunotherapy Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Immunotherapy, Headquarters and Area Served
    Table 22. Global Key Players of Immunotherapy, Product and Application
    Table 23. Global Key Players of Immunotherapy, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Immunotherapy Revenue Market Share by Type (2019-2024)
    Table 27. Global Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Immunotherapy Revenue Market Share by Type (2025-2030)
    Table 29. Global Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Immunotherapy Revenue Share by Application (2019-2024)
    Table 31. Global Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Immunotherapy Revenue Share by Application (2025-2030)
    Table 33. North America Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Immunotherapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Immunotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Immunotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Abbvie Company Details
    Table 66. Abbvie Business Overview
    Table 67. Abbvie Immunotherapy Product
    Table 68. Abbvie Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 69. Abbvie Recent Developments
    Table 70. Amgen, Inc. Company Details
    Table 71. Amgen, Inc. Business Overview
    Table 72. Amgen, Inc. Immunotherapy Product
    Table 73. Amgen, Inc. Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 74. Amgen, Inc. Recent Developments
    Table 75. Biogen Company Details
    Table 76. Biogen Business Overview
    Table 77. Biogen Immunotherapy Product
    Table 78. Biogen Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 79. Biogen Recent Developments
    Table 80. Bristol-Myers Squibb Company Details
    Table 81. Bristol-Myers Squibb Business Overview
    Table 82. Bristol-Myers Squibb Immunotherapy Product
    Table 83. Bristol-Myers Squibb Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 84. Bristol-Myers Squibb Recent Developments
    Table 85. Celgene Company Details
    Table 86. Celgene Business Overview
    Table 87. Celgene Immunotherapy Product
    Table 88. Celgene Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 89. Celgene Recent Developments
    Table 90. Johnson & Johnson Company Details
    Table 91. Johnson & Johnson Business Overview
    Table 92. Johnson & Johnson Immunotherapy Product
    Table 93. Johnson & Johnson Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 94. Johnson & Johnson Recent Developments
    Table 95. Merck Company Details
    Table 96. Merck Business Overview
    Table 97. Merck Immunotherapy Product
    Table 98. Merck Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 99. Merck Recent Developments
    Table 100. Novartis Company Details
    Table 101. Novartis Business Overview
    Table 102. Novartis Immunotherapy Product
    Table 103. Novartis Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 104. Novartis Recent Developments
    Table 105. Pfizer Company Details
    Table 106. Pfizer Business Overview
    Table 107. Pfizer Immunotherapy Product
    Table 108. Pfizer Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 109. Pfizer Recent Developments
    Table 110. Roche Company Details
    Table 111. Roche Business Overview
    Table 112. Roche Immunotherapy Product
    Table 113. Roche Revenue in Immunotherapy Business (2019-2024) & (US$ Million)
    Table 114. Roche Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Immunotherapy Market Share by Type: 2023 VS 2030
    Figure 3. Monoclonal Antibodies Features
    Figure 4. Therapeutic Vaccines Features
    Figure 5. Checkpoint Inhibitors Features
    Figure 6. Non-Specific Immunotherapy Features
    Figure 7. Global Immunotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Immunotherapy Market Share by Application: 2023 VS 2030
    Figure 9. Oncology Case Studies
    Figure 10. Inflammation Case Studies
    Figure 11. Central Nervous System Case Studies
    Figure 12. Others Case Studies
    Figure 13. Immunotherapy Report Years Considered
    Figure 14. Global Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Immunotherapy Market Share by Region: 2023 VS 2030
    Figure 17. Global Immunotherapy Market Share by Players in 2023
    Figure 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Immunotherapy Revenue in 2023
    Figure 20. North America Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Immunotherapy Market Share by Type (2019-2030)
    Figure 22. North America Immunotherapy Market Share by Application (2019-2030)
    Figure 23. North America Immunotherapy Market Share by Country (2019-2030)
    Figure 24. United States Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Immunotherapy Market Share by Type (2019-2030)
    Figure 28. Europe Immunotherapy Market Share by Application (2019-2030)
    Figure 29. Europe Immunotherapy Market Share by Country (2019-2030)
    Figure 30. Germany Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Immunotherapy Market Share by Type (2019-2030)
    Figure 38. China Immunotherapy Market Share by Application (2019-2030)
    Figure 39. Asia Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Immunotherapy Market Share by Type (2019-2030)
    Figure 41. Asia Immunotherapy Market Share by Application (2019-2030)
    Figure 42. Asia Immunotherapy Market Share by Region (2019-2030)
    Figure 43. Japan Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Immunotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Immunotherapy Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Immunotherapy Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Immunotherapy Market Share by Country (2019-2030)
    Figure 53. Brazil Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Abbvie Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 60. Amgen, Inc. Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 61. Biogen Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 63. Celgene Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 66. Novartis Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 67. Pfizer Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 68. Roche Revenue Growth Rate in Immunotherapy Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed